scispace - formally typeset
N

Narayanan Sriram

Researcher at University of Madras

Publications -  12
Citations -  813

Narayanan Sriram is an academic researcher from University of Madras. The author has contributed to research in topics: Pulmonary fibrosis & Bleomycin. The author has an hindex of 12, co-authored 12 publications receiving 721 citations.

Papers
More filters
Journal ArticleDOI

Diallyl sulfide enhances antioxidants and inhibits inflammation through the activation of Nrf2 against gentamicin-induced nephrotoxicity in Wistar rats.

TL;DR: DAS enhances antioxidants and suppresses inflammatory cytokines through the activation of Nrf2, thereby protecting the cell against oxidative stress induced by gentamicin.
Journal ArticleDOI

Epigallocatechin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling.

TL;DR: This study demonstrates the involvement of Nrf2-Keap1 signaling through which EGCG enhances antioxidant activities and Phase II enzymes with subsequent restraint inflammation during bleomycin-induced pulmonary fibrosis.
Journal ArticleDOI

Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: Critical role of iNOS, NF-κB, TNF-α and IL-1β

TL;DR: Evidence is provided that DAS might serve as a novel target for the therapeutic treatment of lung fibrosis.
Journal ArticleDOI

Chromium (VI)-induced oxidative stress and apoptosis is reduced by garlic and its derivative S-allylcysteine through the activation of Nrf2 in the hepatocytes of Wistar rats.

TL;DR: The results show the promising role of Nrf2‐mediated antioxidant defense of AGE and SAC against chromium toxicity, and show the involvement of apoptosis in this study.
Journal ArticleDOI

Diallyl sulfide induces apoptosis in Colo 320 DM human colon cancer cells: involvement of caspase-3, NF-kappaB, and ERK-2.

TL;DR: DAS increased the production of ROS, caused cell cycle arrest, decreased cell proliferation and induced apoptosis in Colo 320 DM cells, putting DAS as a drug that can possibly be used to treat cancers.